# K022489: Summit Medical LTD Celltrans Postoperative Autotransfusion System, Models ABT4510, ABT4512 & ABT4514

- Pathway: 510(k) (Traditional)
- Applicant: Summit Medical, Ltd.
- Decided: Oct 9, 2002 after 72 days
- Product code: CAC (Apparatus, Autotransfusion)
- Device class: 2
- Regulation: 21 CFR 868.5830
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K951592 (1996). 1 ancestor in all.
8 later devices descend from it; 1 cites it directly.
0 of 10 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K951592: Betatrans I and II, Duxbury Scientific, Inc. (1996) Summary page 1.

## Most influential descendants
- K024097: Summit Medical LTD Celltrans Postoperative Autotransfusion Set, Models AB400-10, AB400-12, AB400-14 (2003), 7 descendants of its own
- K210176: FlowSaver Blood Filter (2021), 6 descendants of its own
- K240426: Aventus Clot Management System (2024), 3 descendants of its own
- K253925: Aventus Thrombectomy System (2026), 2 descendants of its own
- K221483: FlowSaver Blood Return System (2023), 1 descendant of its own

## Indications for use
The Summit Medical CellTransTMPostoperative Autotransfusion System is intended for the collection for reinfusion of blood lost by a patient following surgery including but not limited to orthopaedic joint replacement. The device is indicated for autologous blood transfusion.

Source page: https://510kreport.com/device/K022489
Methodology: https://510kreport.com/methodology